Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript - Thomson StreetEvents

Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript

Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript - Thomson StreetEvents
Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript
Published Feb 18, 2022
Published Feb 18, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of AGIO.OQ conference call or presentation 18-Feb-22 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Agios Pharmaceuticals Inc
Ticker
AGIO.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Agios Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-08-04 – US$ 54.00 – Edited Transcript of AGIO.OQ earnings conference call or presentation 4-Aug-22 12:00pm GMT

Agios Pharmaceuticals Inc Leadership Update Transcript – 2022-07-12 – US$ 54.00 – Edited Transcript of AGIO.OQ corporate analyst meeting</ 12-Jul-22 8:30pm GMT

Agios Pharmaceuticals Inc Investor Event (Virtual) Transcript – 2022-06-13 – US$ 54.00 – Edited Transcript of AGIO.OQ corporate analyst meeting</ 13-Jun-22 12:00pm GMT

Agios Pharmaceuticals Inc Q1 2022 Earnings Call Transcript – 2022-05-05 – US$ 54.00 – Edited Transcript of AGIO.OQ earnings conference call or presentation 5-May-22 12:00pm GMT

Agios Pharmaceuticals Inc Q4 2021 Earnings Call Transcript – 2022-02-24 – US$ 54.00 – Edited Transcript of AGIO.OQ earnings conference call or presentation 24-Feb-22 1:00pm GMT

Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2022-01-12 – US$ 54.00 – Edited Transcript of AGIO.OQ presentation 12-Jan-22 12:30pm GMT

Agios Pharmaceuticals Inc to Host Investor Webcast Transcript – 2021-12-14 – US$ 54.00 – Edited Transcript of AGIO.OQ corporate analyst meeting</ 14-Dec-21 12:30pm GMT

Agios Pharmaceuticals Inc Investor Day Transcript – 2021-11-17 – US$ 54.00 – Edited Transcript of AGIO.OQ corporate analyst meeting</ 17-Nov-21 7:00pm GMT

Agios Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-03 – US$ 54.00 – Edited Transcript of AGIO.OQ earnings conference call or presentation 3-Nov-21 12:00pm GMT

Agios Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript – 2021-09-10 – US$ 54.00 – Edited Transcript of AGIO.OQ presentation 10-Sep-21 4:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript" Feb 18, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Agios-Pharmaceuticals-Inc-to-Discuss-the-FDA-Approval-of-PYRUKYND-Call-T15125380>
  
APA:
Thomson StreetEvents. (2022). Agios Pharmaceuticals Inc to Discuss the FDA Approval of PYRUKYND Call Transcript Feb 18, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Agios-Pharmaceuticals-Inc-to-Discuss-the-FDA-Approval-of-PYRUKYND-Call-T15125380>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.